Project Progress Report
6.
Results
Till now, One Hundred Two Migraine patients have been enrolled in the trial. Out of these Forty eight have been given the Ayurvedic
Treatment Protocol and Fifty Four have been given the conventional treatment. A total 102 patients were evaluated who had completed a
treatment of at least 30 days. A significant reduction in pain intensity Scale (VAS) and MIDAS was observed.
Details of Figures:
1. Fig. 1 VAS=Visual Analogue Score
i) Fig. 1(a): Pain Intensity of Ayurvedic Treatment Protocol. VAS=Visual Analogue Score
X-Axis= No. Of Patients
Y-Axis= VAS Score
ii) Fig. 1(b): Pain Intensity of Conventional Treatment Protocol. VAS=Visual Analogue Score
X-Axis= No. Of Patients
Y-Axis= VAS Score
2. Fig. 2 MIDAS= Migraine Disability Assessment Scale
i. Fig. 2(a): Migraine Disability Assessment Scale of Ayurvedic Treatment Protocol.
X-Axis= No. Of Patients
Y-Axis= MIDAS Score
iii) Fig. 2(b): Migraine Disability Assessment Scale of Conventional Treatment Protocol.
X-Axis= No. Of Patients
Y-Axis= MIDAS Score
Rand omized controlled clinical trial to ev aluate prophylactic properties of 7 Ayurv ed ic Treatment Protocol in refractory and ch ronic migraine patients